https://news.medxy.ai/vi/vulvar-cancer-biopsy/Medxy AIvi2026-09-25T08:29:57-07:00Nâng cao sinh thiết hạch lính gác trong ung thư âm hộ: Chẩn ảnh huỳnh quang cận hồng ngoại thời gian thực giúp cải thiện phát hiện và an toàn https://news.medxy.ai/advancing-sentinel-lymph-node-biopsy-in-vulvar-cancer-real-time-near-infrared-fluorescence-imaging-enhances-detection-and-safety/Medxy AIen2026-09-25T08:29:37-07:00Advancing Sentinel Lymph Node Biopsy in Vulvar Cancer: Real-Time Near-Infrared Fluorescence Imaging Enhances Detection and Safety https://news.medxy.ai/zh/social-vulnerability-ovarian-cancer/Medxy AIzh2026-09-25T08:28:56-07:00社会脆弱性与卵巢癌临床试验可及性不平等：美国县级分析 https://news.medxy.ai/ja/ovarian-cancer-trial-disparities/Medxy AIja2026-09-25T08:28:39-07:00社会的脆弱性と結び付く卵巣癌臨床試験アクセス格差：米国郡レベル解析 https://news.medxy.ai/vi/ovarian-cancer-trial-disparities-2/Medxy AIvi2026-09-25T08:28:21-07:00Chênh lệch trong khả năng tiếp cận thử nghiệm lâm sàng ung thư buồng trứng gắn với tính dễ bị tổn thương xã hội: Phân tích ở cấp quận tại Hoa Kỳ https://news.medxy.ai/disparities-in-ovarian-cancer-clinical-trial-access-linked-to-social-vulnerability-a-u-s-county-level-analysis/Medxy AIen2026-09-25T08:28:02-07:00Disparities in Ovarian Cancer Clinical Trial Access Linked to Social Vulnerability: A U.S. County-Level Analysis https://news.medxy.ai/zh/laparoscopic-radiofrequency-ablation-vs-myomectomy/Medxy AIzh2026-09-25T08:27:29-07:00腹腔镜射频消融对比肌瘤切除术：对子宫平滑肌瘤症状与生活质量的影响 https://news.medxy.ai/ja/77829-2/Medxy AIja2026-09-25T08:27:11-07:00腹腔鏡下ラジオ波焼灼術と筋腫核出術の比較：子宮平滑筋腫の症状および生活の質（QOL）への影響 https://news.medxy.ai/vi/uterine-fibroid-treatments/Medxy AIvi2026-09-25T08:26:51-07:00Đốt sóng cao tần nội soi hay bóc nhân xơ tử cung: so sánh hiệu quả trên triệu chứng và chất lượng sống ở u xơ tử cung https://news.medxy.ai/laparoscopic-radiofrequency-ablation-versus-myomectomy-comparative-effects-on-uterine-leiomyoma-symptoms-and-quality-of-life/Medxy AIen2026-09-25T08:26:32-07:00Laparoscopic Radiofrequency Ablation versus Myomectomy: Comparative Effects on Uterine Leiomyoma Symptoms and Quality of Life https://news.medxy.ai/zh/hip-extension-vs-position/Medxy AIzh2026-09-25T08:25:50-07:00胎头拨露时髋关节伸展还是常规体位？对首次阴道分娩会阴裂伤的影响 https://news.medxy.ai/ja/hip-extension-labor/Medxy AIja2026-09-25T08:25:30-07:00娩出直前の股関節伸展は有効か？初回経腟分娩における会陰裂傷への影響 https://news.medxy.ai/vi/77823-2/Medxy AIvi2026-09-25T08:25:09-07:00Việc duỗi khớp háng ngay trước khi sổ thai có hiệu quả không? Ảnh hưởng đến rách tầng sinh môn trong lần sinh thường đầu tiên https://news.medxy.ai/hip-extension-versus-usual-positioning-at-crowning-impact-on-perineal-lacerations-in-first-vaginal-deliveries/Medxy AIen2026-09-25T08:24:51-07:00Hip Extension Versus Usual Positioning at Crowning: Impact on Perineal Lacerations in First Vaginal Deliveries https://news.medxy.ai/zh/new-hope-autoimmune-hepatitis/Medxy AIzh2026-09-25T08:24:13-07:00Zetomipzomib 为难治性自身免疫性肝炎带来新希望：PORTOLA 2a 期研究解读 https://news.medxy.ai/ja/zetomipzomib-potential/Medxy AIja2026-09-25T08:23:52-07:00難治性自己免疫性肝炎に光明か：第2a相PORTOLA試験が示したゼトミプゾミブの可能性 https://news.medxy.ai/vi/zetomipzomib-autoimmune-hepatitis/Medxy AIvi2026-09-25T08:23:29-07:00Zetomipzomib cho thấy triển vọng ở viêm gan tự miễn khó điều trị: Những ghi nhận từ nghiên cứu pha 2a PORTOLA https://news.medxy.ai/zetomipzomib-shows-promise-in-difficult-to-treat-autoimmune-hepatitis-insights-from-the-phase-2a-portola-study/Medxy AIen2026-09-25T08:23:09-07:00Zetomipzomib Shows Promise in Difficult-to-Treat Autoimmune Hepatitis: Insights from the Phase 2a PORTOLA Study https://news.medxy.ai/ja/77783-2/Medxy AIja2026-09-25T08:09:16-07:00入院中のCGM、インスリンポンプ、AIDシステムの安全な使用法：国際的なポジションステートメントの要点解説 https://news.medxy.ai/vi/cgm-insulin-aid-guidelines/Medxy AIvi2026-09-25T08:08:43-07:00Ứng dụng thực hành CGM, bơm insulin và AID trong nội trú: Khuyến nghị then chốt từ một tuyên bố quan điểm quốc tế https://news.medxy.ai/zh/cgm-insulin-pump-aid-safety/Medxy AIzh2026-09-25T08:08:08-07:00住院期如何安全使用CGM、胰岛素泵与AID系统：国际立场声明要点解读 https://news.medxy.ai/practical-inpatient-use-of-cgm-insulin-pumps-and-aid-systems-key-recommendations-from-an-international-position-statement/Medxy AIen2026-09-25T08:07:38-07:00Practical Inpatient Use of CGM, Insulin Pumps, and AID Systems: Key Recommendations from an International Position Statement https://news.medxy.ai/zh/ultrasound-guided-afib-ablation/Medxy AIzh2026-09-25T08:06:39-07:00ULYSSES 试验：超声引导可显著降低心房颤动消融中的血管并发症 https://news.medxy.ai/ja/ulyssses-trial/Medxy AIja2026-09-25T08:06:21-07:00ULYSSES試験：超音波ガイドで心房細動アブレーションの血管合併症が大幅減少 https://news.medxy.ai/vi/ulyssses-ultrasound-guide/Medxy AIvi2026-09-25T08:06:02-07:00Thử nghiệm ULYSSES: Hướng dẫn siêu âm giúp giảm rõ rệt biến chứng mạch máu trong triệt đốt rung nhĩ https://news.medxy.ai/the-ulysses-trial-ultrasound-guidance-significantly-reduces-vascular-complications-in-atrial-fibrillation-ablation/Medxy AIen2026-09-25T08:05:44-07:00The ULYSSES Trial: Ultrasound Guidance Significantly Reduces Vascular Complications in Atrial Fibrillation Ablation https://news.medxy.ai/ja/afib-cardiac-resynchronization/Medxy AIja2026-09-25T08:05:00-07:00心房細動における心臓再同期療法：房室結節アブレーション併用の有無を比較したCAAN-AF試験 https://news.medxy.ai/vi/cardiac-resynchronization-af/Medxy AIvi2026-09-25T08:04:40-07:00Liệu pháp tái đồng bộ tim trong rung nhĩ: có cần triệt đốt nút nhĩ thất hay không? Kết quả thử nghiệm CAAN-AF https://news.medxy.ai/cardiac-resynchronization-therapy-with-or-without-atrioventricular-node-ablation-in-atrial-fibrillation-the-caan-af-trial/Medxy AIen2026-09-25T08:04:23-07:00Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF Trial https://news.medxy.ai/zh/mtmr4-gene-variants/Medxy AIzh2026-09-25T08:03:46-07:00MTMR4基因变异：在1型与2型长QT综合征中的致心律失常风险呈相反影响 https://news.medxy.ai/ja/mtmr4-gene-variants-2/Medxy AIja2026-09-25T08:03:25-07:00MTMR4基因变异：对1型与2型长QT综合征心律失常风险的相反影响 https://news.medxy.ai/vi/mtmr4-gen-variant-risk/Medxy AIvi2026-09-25T08:03:06-07:00Biến thể gen MTMR4: Tác động trái ngược lên nguy cơ loạn nhịp trong hội chứng QT dài тип 1 và тип 2 https://news.medxy.ai/mtmr4-gene-variants-divergent-impact-on-arrhythmic-risk-in-type-1-and-2-long-qt-syndrome/Medxy AIen2026-09-25T08:02:46-07:00MTMR4 Gene Variants: Divergent Impact on Arrhythmic Risk in Type 1 and 2 Long QT Syndrome https://news.medxy.ai/zh/atrial-mechanical-dysfunction/Medxy AIzh2026-09-25T08:02:04-07:00窦性心律下转甲状腺素蛋白淀粉样变性心肌病患者的心房机械功能障碍：卒中风险的新预测因子 https://news.medxy.ai/ja/atrial-function-stroke-risk/Medxy AIja2026-09-25T08:01:45-07:00洞調律のトランスサイレチンアミロイド心筋症における心房機械機能障害は脳卒中リスクの有力予測因子 https://news.medxy.ai/vi/atrial-mechanical-dysfunction-stroke-risk/Medxy AIvi2026-09-25T08:01:20-07:00Rối loạn chức năng cơ học nhĩ: dấu ấn dự báo nguy cơ đột quỵ ở bệnh nhân bệnh cơ tim nhiễm amyloid transthyretin còn nhịp xoang https://news.medxy.ai/atrial-mechanical-dysfunction-as-a-predictor-of-stroke-risk-in-transthyretin-amyloid-cardiomyopathy-patients-in-sinus-rhythm/Medxy AIen2026-09-25T08:00:59-07:00Atrial Mechanical Dysfunction as a Predictor of Stroke Risk in Transthyretin Amyloid Cardiomyopathy Patients in Sinus Rhythm https://news.medxy.ai/zh/77759-2/Medxy AIzh2026-09-25T08:00:18-07:00心脏淀粉样变性中潜藏的心律失常负荷 https://news.medxy.ai/ja/amyloidosis-arrhythmia-excalibur/Medxy AIja2026-09-25T07:59:58-07:00心アミロイドーシスに潜む不整脈負荷：EXCALIBUR植込み型ループレコーダー研究から見えた知見 https://news.medxy.ai/vi/arrhythmia-amyloidosis-heart/Medxy AIvi2026-09-25T07:59:36-07:00Gánh nặng rối loạn nhịp trong amyloidosis tim: Những phát hiện từ nghiên cứu EXCALIBUR với thiết bị ghi nhận nhịp tim cấy ghép https://news.medxy.ai/unveiling-arrhythmic-burden-in-cardiac-amyloidosis-insights-from-the-excalibur-implantable-loop-recorder-study/Medxy AIen2026-09-25T07:59:16-07:00Unveiling Arrhythmic Burden in Cardiac Amyloidosis: Insights from the EXCALIBUR Implantable Loop Recorder Study https://news.medxy.ai/zh/ldl-cholesterol-thrombosis-risk/Medxy AIzh2026-09-25T07:58:29-07:00遗传决定的 LDL 胆固醇差异与静脉血栓栓塞风险：影响有限 https://news.medxy.ai/ja/ldl-genetic-risk/Medxy AIja2026-09-25T07:58:10-07:00LDLコレステロールの遺伝的差異と静脈血栓塞栓症リスクへの限定的な影響 https://news.medxy.ai/vi/ldl-cholesterol-variation/Medxy AIvi2026-09-25T07:57:48-07:00Biến thiên LDL cholesterol do di truyền và tác động hạn chế lên nguy cơ huyết khối tĩnh mạch thuyên tắc https://news.medxy.ai/genetically-mediated-ldl-cholesterol-variations-and-their-limited-impact-on-venous-thromboembolism-risk/Medxy AIen2026-09-25T07:57:27-07:00Genetically Mediated LDL Cholesterol Variations and Their Limited Impact on Venous Thromboembolism Risk https://news.medxy.ai/zh/77749-2/Medxy AIzh2026-09-25T07:56:44-07:00FFR-CT改善稳定性冠状动脉疾病预后的潜力 https://news.medxy.ai/ja/ffr-ct-coronary-disease/Medxy AIja2026-09-25T07:56:24-07:00安定冠動脈疾患の予後を高めるFFR-CTの可能性：全国コホート研究が示す新知見 https://news.medxy.ai/vi/77747-2/Medxy AIvi2026-09-25T07:56:02-07:00Tiềm năng của FFR-CT trong việc cải thiện tiên lượng bệnh động mạch vành ổn định https://news.medxy.ai/enhancing-prognosis-in-stable-coronary-artery-disease-insights-from-a-nationwide-cohort-on-ffr-ct/Medxy AIen2026-09-25T07:55:40-07:00Enhancing Prognosis in Stable Coronary Artery Disease: Insights from a Nationwide Cohort on FFR-CT https://news.medxy.ai/zh/77744-2/Medxy AIzh2026-09-25T07:54:54-07:00血管外植入式除颤器的临床实际应用结果：来自Enlighten上市后注册研究的发现 https://news.medxy.ai/ja/icd-clinical-results/Medxy AIja2026-09-25T07:54:33-07:00血管外植込み型除細動器の実臨床成績：Enlighten市販後レジストリからの知見 https://news.medxy.ai/vi/ev-icd-clinical-results/Medxy AIvi2026-09-25T07:54:09-07:00EV-ICD trong thực hành lâm sàng: Kết quả 1 năm từ Enlighten Post Approval Registry https://news.medxy.ai/real-world-outcomes-of-the-extravascular-implantable-cardioverter-defibrillator-insights-from-the-enlighten-post-approval-registry/Medxy AIen2026-09-25T07:53:47-07:00Real-World Outcomes of the Extravascular Implantable Cardioverter Defibrillator: Insights from the Enlighten Post Approval Registry https://news.medxy.ai/zh/sotatercept-pulmonary-hypertension-2/Medxy AIzh2026-09-25T07:53:00-07:00Sotatercept通过优化肺动脉高压的心脏力学改善右心功能 https://news.medxy.ai/ja/77738-2/Medxy AIja2026-09-25T07:52:40-07:00ソタテルセプトは、肺動脈性肺高血圧症における心臓の力学特性を最適化することで、右心機能を改善する https://news.medxy.ai/vi/sotatercept-heart-function/Medxy AIvi2026-09-25T07:52:17-07:00Sotatercept giúp tối ưu cơ học để cải thiện chức năng tim phải trong tăng áp động mạch phổi https://news.medxy.ai/sotatercept-enhances-right-heart-function-by-optimizing-mechanics-in-pulmonary-arterial-hypertension/Medxy AIen2026-09-25T07:51:58-07:00Sotatercept Enhances Right Heart Function by Optimizing Mechanics in Pulmonary Arterial Hypertension https://news.medxy.ai/zh/gastrointestinal-sensation-anorexia/Medxy AIzh2026-09-25T05:58:15-07:00神经性厌食症中的胃肠内感受与复发：来自行为、神经与计算视角的启示 https://news.medxy.ai/ja/gastointestinal-interoception-anorexia/Medxy AIja2026-09-25T05:57:51-07:00神経性やせ症の再発を左右する胃腸インターセプション：行動・神経・計算論の視点から https://news.medxy.ai/vi/77679-2/Medxy AIvi2026-09-25T05:57:24-07:00Cảm nhận nội tại từ đường tiêu hóa và sự tái phát bệnh chán ăn tâm thần: Những hiểu biết từ các góc độ hành vi, thần kinh và tính toán https://news.medxy.ai/gastrointestinal-interoception-and-relapse-in-anorexia-nervosa-insights-from-behavioral-neural-and-computational-perspectives/Medxy AIen2026-09-25T05:57:00-07:00Gastrointestinal Interoception and Relapse in Anorexia Nervosa: Insights from Behavioral, Neural, and Computational Perspectives https://news.medxy.ai/zh/77676-2/Medxy AIzh2026-09-25T05:56:00-07:00急诊科急救医疗服务设备的使用与院外心脏骤停患者的救治时间有关 https://news.medxy.ai/ja/77675-2/Medxy AIja2026-09-25T05:55:37-07:00救急外来における救急医療機器の使用は、院外心停止患者の救命処置にかかる時間と関連している https://news.medxy.ai/vi/77674-2/Medxy AIvi2026-09-25T05:55:05-07:00Việc sử dụng trang thiết bị của dịch vụ y tế khẩn cấp tại khoa cấp cứu có liên quan đến thời gian điều trị cho bệnh nhân bị ngừng tuần hoàn ngoài bệnh viện https://news.medxy.ai/zh/nmospd-mri-diagnosis/Medxy AIzh2026-09-25T05:07:35-07:00AQP4-IgG阳性NMOSD脊髓炎诊断再提升：新旧脊髓MRI征象的价值 https://news.medxy.ai/ja/nmospd-spinal-mri/Medxy AIja2026-09-25T05:07:16-07:00AQP4-IgG陽性NMOSD脊髄炎の診断を高める：新規および既知の脊髄MRI所見の意義 https://news.medxy.ai/vi/nmosd-spine-mri/Medxy AIvi2026-09-25T05:06:53-07:00Nâng cao chẩn đoán viêm tủy do NMOSD AQP4-IgG dương tính: Vai trò của các dấu hiệu MRI tủy sống mới và kinh điển https://news.medxy.ai/enhancing-diagnosis-of-aqp4-igg-nmosd-myelitis-the-role-of-novel-and-established-spinal-mri-signs/Medxy AIen2026-09-25T05:06:33-07:00Enhancing Diagnosis of AQP4-IgG+ NMOSD Myelitis: The Role of Novel and Established Spinal MRI Signs https://news.medxy.ai/zh/guilt-diabetes-emotions-2/Medxy AIzh2026-09-25T05:05:47-07:00内疚感在糖尿病每日情绪负担中的核心作用：来自高密度纵向网络分析的启示 https://news.medxy.ai/ja/guilt-diabetes-emotions/Medxy AIja2026-09-25T05:05:21-07:00糖尿病の日常的な感情負担における罪悪感の中心的役割：集中的縦断ネットワーク解析からの知見 https://news.medxy.ai/vi/guilt-emotion-diabetes/Medxy AIvi2026-09-25T05:04:57-07:00Vai trò trung tâm của cảm giác tội lỗi trong gánh nặng cảm xúc đặc hiệu cho đái tháo đường hằng ngày: Góc nhìn từ phân tích mạng lưới dọc chuyên sâu https://news.medxy.ai/the-central-role-of-guilt-in-daily-diabetes-specific-emotional-burdens-insights-from-intensive-longitudinal-network-analysis/Medxy AIen2026-09-25T05:04:35-07:00The Central Role of Guilt in Daily Diabetes-Specific Emotional Burdens: Insights from Intensive Longitudinal Network Analysis https://news.medxy.ai/zh/bronchiectasis-prevalence-us/Medxy AIzh2026-09-25T05:03:50-07:00美国基层医疗中非囊性纤维化支气管扩张症患病率持续上升：基于十年电子健康记录的观察 https://news.medxy.ai/ja/77695-2/Medxy AIja2026-09-25T05:03:36-07:00米国のプライマリ・ケアにおける非嚢胞性線維症気管支拡張症の有病率の継続的上昇 https://news.medxy.ai/vi/non-cystic-bronchiectasis-us/Medxy AIvi2026-09-25T05:03:17-07:00Giãn phế quản không do xơ nang gia tăng trong chăm sóc ban đầu tại Hoa Kỳ: Góc nhìn từ dữ liệu hồ sơ sức khỏe điện tử suốt một thập kỷ https://news.medxy.ai/rising-prevalence-of-non-cystic-fibrosis-bronchiectasis-in-us-primary-care-insights-from-a-decade-of-electronic-health-records/Medxy AIen2026-09-25T05:02:58-07:00Rising Prevalence of Non-Cystic Fibrosis Bronchiectasis in US Primary Care: Insights from a Decade of Electronic Health Records https://news.medxy.ai/zh/mucus-plug-copd/Medxy AIzh2026-09-25T05:02:13-07:00黏液栓-肺气肿混合亚型与COPD急性加重：基于定量CT的分型研究 https://news.medxy.ai/ja/copd-mucus-emphysema/Medxy AIja2026-09-25T05:01:52-07:00COPDにおける粘液栓・肺気腫混合サブタイプと急性増悪：定量CTによる表現型解析 https://news.medxy.ai/vi/copd-phenotypes-ct/Medxy AIvi2026-09-25T05:01:29-07:00Phân kiểu COPD dựa trên nút nhầy–khí phế thũng và nguy cơ đợt cấp: tiếp cận bằng CT định lượng https://news.medxy.ai/mixed-mucus-plug-emphysema-subtype-and-acute-exacerbation-in-chronic-obstructive-pulmonary-disease-a-quantitative-ct-phenotyping-approach/Medxy AIen2026-09-25T05:01:04-07:00Mixed Mucus Plug-Emphysema Subtype and Acute Exacerbation in Chronic Obstructive Pulmonary Disease: A Quantitative CT Phenotyping Approach https://news.medxy.ai/zh/77456-2/Medxy AIzh2026-09-24T09:47:27-07:00英格兰 COVID-19 疫苗接种推广期间及之后，严重精神障碍患者感染 SARS-CoV-2 后的死亡率差异 https://news.medxy.ai/ja/77454-2/Medxy AIja2026-09-24T09:47:06-07:00イングランドにおけるCOVID-19ワクチン接種の展開期間中およびその後の、重度精神疾患を有する人々のSARS-CoV-2感染後の死亡率の不平等 https://news.medxy.ai/vi/77451-2/Medxy AIvi2026-09-24T09:46:42-07:00Sự chênh lệch về tỷ lệ tử vong sau khi nhiễm SARS-CoV-2 ở người mắc bệnh tâm thần nặng trong và sau giai đoạn triển khai tiêm chủng COVID-19 tại Anh https://news.medxy.ai/inequalities-in-mortality-following-sars-cov-2-infection-among-people-with-severe-mental-illness-during-and-after-covid-19-vaccination-roll-out-in-england-a-comprehensive-review/Medxy AIen2026-09-24T09:46:20-07:00Inequalities in Mortality Following SARS-CoV-2 Infection Among People with Severe Mental Illness During and After COVID-19 Vaccination Roll-Out in England: A Comprehensive Review https://news.medxy.ai/zh/schizophrenia-bipolar-comorbidity-2/Medxy AIzh2026-09-24T09:45:29-07:00精神分裂症谱系障碍与双相障碍中系统性躯体多病共存：来自昆士兰医院队列研究的启示 https://news.medxy.ai/ja/schizophrenia-bipolar-comorbidity/Medxy AIja2026-09-24T09:45:09-07:00統合失調症スペクトラム障害と双極性障害における早期かつ高度な全身性身体多疾患併存：クイーンズランド病院コホート研究からの知見 https://news.medxy.ai/vi/early-onset-multimorbidity/Medxy AIvi2026-09-24T09:44:49-07:00Khởi phát sớm và gánh nặng đa bệnh lý thể chất hệ thống gia tăng ở rối loạn phổ tâm thần phân liệt và rối loạn lưỡng cực: bằng chứng từ một nghiên cứu đoàn hệ bệnh viện tại Queensland https://news.medxy.ai/early-and-elevated-systemic-physical-multimorbidity-in-schizophrenia-spectrum-and-bipolar-disorders-insights-from-a-queensland-hospital-cohort-study/Medxy AIen2026-09-24T09:44:30-07:00Early and Elevated Systemic Physical Multimorbidity in Schizophrenia-Spectrum and Bipolar Disorders: Insights from a Queensland Hospital Cohort Study https://news.medxy.ai/zh/brain-structure-changes-3/Medxy AIzh2026-09-24T09:43:49-07:00神经性贪食症的脑结构改变：ENIGMA联合分析带来新认识 https://news.medxy.ai/ja/brain-structure-changes-2/Medxy AIja2026-09-24T09:43:31-07:00神経性過食症にみられる脳構造変化を解明：ENIGMA共同解析が示す知見 https://news.medxy.ai/vi/vomiting-brain-changes/Medxy AIvi2026-09-24T09:43:09-07:00Chứng ăn ói: Những thay đổi cấu trúc não được hé lộ từ phân tích ENIGMA https://news.medxy.ai/unveiling-brain-structural-changes-in-bulimia-nervosa-insights-from-the-enigma-consortium-analysis/Medxy AIen2026-09-24T09:42:48-07:00Unveiling Brain Structural Changes in Bulimia Nervosa: Insights from the ENIGMA Consortium Analysis https://news.medxy.ai/zh/asd-adhd-genetic-trends/Medxy AIzh2026-09-24T09:42:05-07:00ASD与ADHD遗传贡献的变化：从诊断趋势看1994—2016年的新发现 https://news.medxy.ai/ja/asd-adhd-genetics/Medxy AIja2026-09-24T09:41:47-07:00ASD・ADHDの遺伝的背景はどう変わったのか：診断動向（1994～2016年）からみる最新知見 https://news.medxy.ai/vi/asd-adhd-genetic-risk/Medxy AIvi2026-09-24T09:41:27-07:00ASD và ADHD: nguy cơ di truyền thay đổi theo xu hướng chẩn đoán (1994–2016) https://news.medxy.ai/asd-adhd-genetics-2/Medxy AIen2026-09-24T09:41:08-07:00Evolving Genetic Contributions to ASD and ADHD: Insights from Diagnosis Trends (1994–2016) https://news.medxy.ai/zh/ilofotase-alfa-prevention/Medxy AIzh2026-09-24T09:14:27-07:00Ilofotase Alfa 预防心脏手术后急性肾损伤：来自2期随机试验的启示 https://news.medxy.ai/ja/ilofotase-alfa-kidney-injury/Medxy AIja2026-09-24T09:14:10-07:00心臓手術後の急性腎障害予防におけるIlofotase alfa：第2相無作為化試験から得られた知見 https://news.medxy.ai/vi/ilofotase-alfa-kidney-injury-prevention/Medxy AIvi2026-09-24T09:13:53-07:00Ilofotase Alfa trong phòng ngừa tổn thương thận cấp sau phẫu thuật tim: Góc nhìn từ thử nghiệm ngẫu nhiên pha 2 https://news.medxy.ai/ilofotase-alfa-in-preventing-acute-kidney-injury-post-cardiac-surgery-insights-from-a-phase-2-randomized-trial/Medxy AIen2026-09-24T09:13:34-07:00Ilofotase Alfa in Preventing Acute Kidney Injury Post-Cardiac Surgery: Insights from a Phase 2 Randomized Trial https://news.medxy.ai/zh/covid19-risk-factors/Medxy AIzh2026-09-24T09:12:53-07:00瑞典全国队列揭示：COVID-19 重症预测因素如何演变，并与季节性流感对照 https://news.medxy.ai/ja/covid19-severity-factors/Medxy AIja2026-09-24T09:12:37-07:00季節性インフルエンザと比較した重症COVID-19の予測因子の変遷：スウェーデン全国コホートからの知見 https://news.medxy.ai/vi/covid19-severity-factors-2/Medxy AIvi2026-09-24T09:12:16-07:00Các yếu tố dự báo bệnh nặng của COVID-19 thay đổi ra sao so với cúm mùa? Dữ liệu từ một đoàn hệ toàn quốc ở Thụy Điển https://news.medxy.ai/evolving-predictors-of-severe-covid-19-compared-to-seasonal-influenza-insights-from-a-nationwide-swedish-cohort/Medxy AIen2026-09-24T09:11:58-07:00Evolving Predictors of Severe COVID-19 Compared to Seasonal Influenza: Insights from a Nationwide Swedish Cohort https://news.medxy.ai/zh/77357-2/Medxy AIzh2026-09-24T09:11:21-07:00肝硬化危重症患者接受 CRRT 治疗的流行病学特征与预后：基于 HRS-HARMONY 和 CRRTnet 注册研究的分析 https://news.medxy.ai/ja/77356-2/Medxy AIja2026-09-24T09:11:01-07:00重症肝硬変患者におけるCRRTの疫学と転帰：HRS-HARMONYおよびCRRTnetレジストリからの知見 https://news.medxy.ai/vi/crrt-cirrhosis-outcomes/Medxy AIvi2026-09-24T09:10:41-07:00Dịch tễ học và kết cục của CRRT ở bệnh nhân xơ gan nguy kịch: Góc nhìn từ các cơ sở đăng ký HRS-HARMONY và CRRTnet https://news.medxy.ai/epidemiology-and-outcomes-of-crrt-in-critically-ill-cirrhosis-patients-insights-from-the-hrs-harmony-and-crrtnet-registries/Medxy AIen2026-09-24T09:10:22-07:00Epidemiology and Outcomes of CRRT in Critically Ill Cirrhosis Patients: Insights from the HRS-HARMONY and CRRTnet Registries https://news.medxy.ai/zh/tbi-epilepsy-risk/Medxy AIzh2026-09-24T09:09:27-07:00老年TBI幸存者使用抗精神病药后癫痫风险：来自人群队列研究的启示 https://news.medxy.ai/ja/epilepsy-risk-antipsychotics/Medxy AIja2026-09-24T09:09:08-07:00高齢TBI生存者における抗精神病薬使用後のてんかんリスク：集団ベースコホート研究からの知見 https://news.medxy.ai/vi/epilepsy-risk-antipsychotics-elderly/Medxy AIvi2026-09-24T09:08:48-07:00Nguy cơ động kinh sau khi dùng thuốc chống loạn thần ở người cao tuổi sống sót sau chấn thương sọ não: Bằng chứng từ một nghiên cứu đoàn hệ dựa trên quần thể https://news.medxy.ai/epilepsy-risk-following-antipsychotic-use-in-older-traumatic-brain-injury-survivors-insights-from-a-population-based-cohort-study/Medxy AIen2026-09-24T09:08:29-07:00Epilepsy Risk Following Antipsychotic Use in Older Traumatic Brain Injury Survivors: Insights from a Population-Based Cohort Study https://news.medxy.ai/zh/ketamine-injection-comparison/Medxy AIzh2026-09-24T09:07:39-07:00急诊创伤疼痛中鼻内与皮下注射氯胺酮：疗效与安全性相当 https://news.medxy.ai/ja/ketamine-acute-trauma-pain/Medxy AIja2026-09-24T09:07:22-07:00救急外来の急性外傷疼痛に対するケタミン：経鼻投与と皮下投与の比較 https://news.medxy.ai/vi/ketamine-administration-methods/Medxy AIvi2026-09-24T09:07:02-07:00Ketamine đường mũi hay tiêm dưới da trong đau chấn thương cấp tại khoa cấp cứu: Hiệu quả và độ an toàn tương đương https://news.medxy.ai/intranasal-vs-subcutaneous-ketamine-for-acute-traumatic-pain-in-the-ed-comparable-efficacy-and-safety/Medxy AIen2026-09-24T09:06:44-07:00Intranasal vs. Subcutaneous Ketamine for Acute Traumatic Pain in the ED: Comparable Efficacy and Safety https://news.medxy.ai/zh/sphenopalatine-ganglion-blockade/Medxy AIzh2026-09-24T09:06:03-07:00急诊头痛患者蝶腭神经节阻滞：布比卡因剂量是否影响缓解效果？ https://news.medxy.ai/ja/optimal-dose-nerve-block/Medxy AIja2026-09-24T09:05:43-07:00救急外来の頭痛に対する蝶口蓋神経節ブロックの至適投与量を検証 https://news.medxy.ai/vi/pterygopalatine-blockade-pain/Medxy AIvi2026-09-24T09:05:23-07:00Đánh giá liều phong bế hạch chân bướm–khẩu cái trong giảm đau đầu tại khoa cấp cứu https://news.medxy.ai/evaluating-sphenopalatine-ganglion-block-dosage-for-headache-relief-in-the-emergency-department/Medxy AIen2026-09-24T09:05:05-07:00Evaluating Sphenopalatine Ganglion Block Dosage for Headache Relief in the Emergency Department https://news.medxy.ai/zh/fruit-vegetable-dose-effect/Medxy AIzh2026-09-24T08:59:29-07:00果蔬处方的剂量效应：来自随机社区试验及更广泛证据的启示 https://news.medxy.ai/ja/dose-effect/Medxy AIja2026-09-24T08:59:13-07:00処方量で変わる効果――produce prescriptionの用量反応を示した地域ランダム化試験と最新エビデンス https://news.medxy.ai/vi/fresh-food-prescription/Medxy AIvi2026-09-24T08:58:52-07:00Kê đơn thực phẩm tươi: tác động phụ thuộc liều và ý nghĩa từ một thử nghiệm cộng đồng ngẫu nhiên https://news.medxy.ai/dose-dependent-effects-of-produce-prescriptions-insights-from-a-randomized-community-trial-and-broader-evidence/Medxy AIen2026-09-24T08:58:32-07:00Dose-Dependent Effects of Produce Prescriptions: Insights from a Randomized Community Trial and Broader Evidence https://news.medxy.ai/zh/medicaid-prescription-impact/Medxy AIzh2026-09-24T08:57:48-07:00取消 Medicaid 处方限额对 HIV 患者 ART 依从性及医疗利用的影响 https://news.medxy.ai/ja/medicaid-hiv-art-impact/Medxy AIja2026-09-24T08:57:32-07:00Medicaid処方上限撤廃がHIV患者のART服薬遵守と医療利用に与えた影響 https://news.medxy.ai/vi/medicaid-prescription-limit-impact/Medxy AIvi2026-09-24T08:57:12-07:00Bãi bỏ trần đơn thuốc Medicaid ảnh hưởng thế nào đến tuân thủ ART và sử dụng dịch vụ y tế ở người nhiễm HIV? https://news.medxy.ai/impact-of-medicaid-prescription-cap-removal-on-art-adherence-and-health-care-utilization-among-people-with-hiv/Medxy AIen2026-09-24T08:56:52-07:00Impact of Medicaid Prescription Cap Removal on ART Adherence and Health Care Utilization Among People with HIV https://news.medxy.ai/zh/hypertension-management/Medxy AIzh2026-09-24T08:56:15-07:00住院患者无症状血压升高该如何处理？全美调查揭示医师观点分歧 https://news.medxy.ai/ja/asymptomatic-hypertension-management/Medxy AIja2026-09-24T08:55:59-07:00入院患者の無症候性高血圧をどう扱うか：病院勤務医の認識を全国調査で探る https://news.medxy.ai/vi/hypertension-management-2/Medxy AIvi2026-09-24T08:55:39-07:00Quan điểm của bác sĩ về xử trí tăng huyết áp không triệu chứng ở bệnh nhân nằm viện: Phân tích từ một khảo sát toàn quốc https://news.medxy.ai/physicians-perspectives-on-managing-asymptomatic-elevated-blood-pressure-in-hospitalized-patients-insights-from-a-nationwide-survey/Medxy AIen2026-09-24T08:55:22-07:00Physicians’ Perspectives on Managing Asymptomatic Elevated Blood Pressure in Hospitalized Patients: Insights from a Nationwide Survey https://news.medxy.ai/zh/fatty-liver-risk-score/Medxy AIzh2026-09-24T08:54:46-07:00脂肪性肝病风险评分：预测肝硬化与肝细胞癌的临床价值综述 https://news.medxy.ai/ja/fatty-liver-risk/Medxy AIja2026-09-24T08:54:26-07:00脂肪性肝疾患のリスクスコアで肝硬変と肝細胞癌を予測する：包括的臨床レビュー https://news.medxy.ai/vi/fatty-liver-risk-2/Medxy AIvi2026-09-24T08:54:02-07:00Điểm nguy cơ bệnh gan nhiễm mỡ trong dự đoán xơ gan và ung thư gan: Tổng quan lâm sàng toàn diện https://news.medxy.ai/steatotic-liver-disease-risk-scores-for-predicting-cirrhosis-and-hepatocellular-carcinoma-a-comprehensive-clinical-review/Medxy AIen2026-09-24T08:53:41-07:00Steatotic Liver Disease Risk Scores for Predicting Cirrhosis and Hepatocellular Carcinoma: A Comprehensive Clinical Review https://news.medxy.ai/zh/post-covid-car-t-infection/Medxy AIzh2026-09-24T08:52:51-07:00后疫情时代造血细胞与 CAR T 细胞治疗受者呼吸道病毒感染格局的演变 https://news.medxy.ai/ja/post-covid-respiratory-infections/Medxy AIja2026-09-24T08:52:35-07:00COVID-19流行後に変化する、造血細胞移植・CAR T細胞療法受療者の呼吸器ウイルス感染症の実態 https://news.medxy.ai/vi/respiratory-virus-trends/Medxy AIvi2026-09-24T08:52:16-07:00Xu hướng mới của nhiễm vi-rút hô hấp ở người nhận ghép tế bào tạo máu và liệu pháp tế bào CAR T sau đại dịch COVID-19 https://news.medxy.ai/evolving-landscape-of-respiratory-viral-infections-in-hematopoietic-cellular-and-car-t-cell-therapy-recipients-post-covid-19-pandemic/Medxy AIen2026-09-24T08:51:56-07:00Evolving Landscape of Respiratory Viral Infections in Hematopoietic Cellular and CAR T-cell Therapy Recipients Post-COVID-19 Pandemic https://news.medxy.ai/zh/bcr-abl1-aml-treatment/Medxy AIzh2026-09-24T08:51:19-07:00BCR::ABL1 阳性急性髓系白血病治疗新进展：强化化疗联合酪氨酸激酶抑制剂的临床价值 https://news.medxy.ai/ja/bcr-abl1-leukemia-treatment/Medxy AIja2026-09-24T08:51:02-07:00初発BCR::ABL1陽性急性骨髄性白血病の治療を前進させる：集学的化学療法とチロシンキナーゼ阻害薬併用の意義 https://news.medxy.ai/vi/new-aml-treatment/Medxy AIvi2026-09-24T08:50:45-07:00Mở ra hướng điều trị mới cho AML BCR::ABL1+ de novo: Tác động của việc phối hợp hóa trị liệu cường độ cao với chất ức chế tyrosine kinase https://news.medxy.ai/advancing-treatment-in-de-novo-bcrabl1-acute-myeloid-leukemia-the-impact-of-combining-intensive-chemotherapy-with-tyrosine-kinase-inhibitors/Medxy AIen2026-09-24T08:50:28-07:00Advancing Treatment in De Novo BCR::ABL1+ Acute Myeloid Leukemia: The Impact of Combining Intensive Chemotherapy with Tyrosine Kinase Inhibitors https://news.medxy.ai/zh/targeting-igf2bp2/Medxy AIzh2026-09-24T08:49:51-07:00靶向IGF2BP2：RNA修饰与免疫调控驱动外周T细胞淋巴瘤治疗新路径 https://news.medxy.ai/ja/igf2bp2-therapy/Medxy AIja2026-09-24T08:49:32-07:00IGF2BP2を標的とする新規治療戦略：RNA修飾と免疫調節からみた末梢性T細胞リンパ腫への展望 https://news.medxy.ai/vi/igf2bp2-therapy-2/Medxy AIvi2026-09-24T08:49:11-07:00Nhắm vào IGF2BP2: Hướng điều trị mới cho u lympho tế bào T ngoại vi thông qua biến đổi RNA và điều hòa miễn dịch https://news.medxy.ai/targeting-igf2bp2-a-novel-therapeutic-avenue-in-peripheral-t-cell-lymphoma-through-rna-modification-and-immune-modulation/Medxy AIen2026-09-24T08:48:51-07:00Targeting IGF2BP2: A Novel Therapeutic Avenue in Peripheral T-cell Lymphoma Through RNA Modification and Immune Modulation https://news.medxy.ai/zh/77215-2/Medxy AIzh2026-09-24T08:48:11-07:00RAS通路激活是AML中FLT3及BCL2抑制剂耐药的关键 https://news.medxy.ai/ja/flt3-bcl2-resistance-aml/Medxy AIja2026-09-24T08:47:54-07:00AMLにおけるFLT3・BCL2阻害耐性の鍵を握るRAS経路活性化――遺伝学的・非遺伝学的機序の動的変化 https://news.medxy.ai/vi/77213-2/Medxy AIvi2026-09-24T08:47:33-07:00Sự kích hoạt con đường RAS – yếu tố then chốt dẫn đến kháng thuốc ức chế FLT3 và BCL2 trong AML https://news.medxy.ai/dynamic-genetic-and-nongenetic-ras-pathway-activation-drives-resistance-to-flt3-and-bcl2-inhibitor-therapy-in-aml/Medxy AIen2026-09-24T08:47:13-07:00Dynamic Genetic and Nongenetic RAS-Pathway Activation Drives Resistance to FLT3 and BCL2 Inhibitor Therapy in AML https://news.medxy.ai/zh/malignant-pleural-effusion-diagnosis/Medxy AIzh2026-09-24T08:46:26-07:00恶性胸腔积液诊断中：胸腔穿刺与胸腔镜，哪种更具成本效益？ https://news.medxy.ai/ja/malignant-pleural-effusion-diagnosis-2/Medxy AIja2026-09-24T08:46:08-07:00悪性胸水の診断：胸腔穿刺と胸腔鏡下胸膜生検、どちらが費用対効果に優れるか https://news.medxy.ai/vi/cost-effectiveness-pleural-biopsy/Medxy AIvi2026-09-24T08:45:44-07:00Hiệu quả chi phí của chọc dò màng phổi kèm tế bào học dịch màng phổi so với nội soi lồng ngực kèm sinh thiết màng phổi trong chẩn đoán tràn dịch màng phổi ác tính https://news.medxy.ai/cost-effectiveness-of-thoracentesis-with-pleural-fluid-cytology-versus-thoracoscopy-with-pleural-biopsy-in-diagnosing-malignant-pleural-effusion/Medxy AIen2026-09-24T08:45:24-07:00Cost-Effectiveness of Thoracentesis with Pleural Fluid Cytology Versus Thoracoscopy with Pleural Biopsy in Diagnosing Malignant Pleural Effusion https://news.medxy.ai/zh/77192-2/Medxy AIzh2026-09-24T08:30:11-07:00定量CT显示的COPD新分类：黏液栓与肺气肿的混合表型可预测急性加重风险 https://news.medxy.ai/ja/copd-ct-classification/Medxy AIja2026-09-24T08:29:51-07:00定量的CTで見えるCOPDの新分類：粘液栓・肺気腫の混合表現型が増悪リスクを予測する https://news.medxy.ai/vi/mucus-airway-phenotype/Medxy AIvi2026-09-24T08:29:25-07:00Kiểu hình hóa phối hợp nút nhầy–khí phế thũng trên CT định lượng dự báo nguy cơ đợt cấp trong COPD: Tích hợp dấu ấn sinh học hình ảnh cho y học chính xác https://news.medxy.ai/quantitative-ct-based-mixed-mucus-plug-emphysema-phenotyping-predicts-exacerbation-risk-in-copd-integrating-imaging-biomarkers-for-precision-medicine/Medxy AIen2026-09-24T08:29:01-07:00Quantitative CT-Based Mixed Mucus Plug-Emphysema Phenotyping Predicts Exacerbation Risk in COPD: Integrating Imaging Biomarkers for Precision Medicine https://news.medxy.ai/zh/us-bronchiectasis-trends/Medxy AIzh2026-09-24T08:07:07-07:00美国初级保健中非囊性纤维化支气管扩张症负担持续上升：2015—2025年患病趋势与人口学特征分析 https://news.medxy.ai/ja/77186-2/Medxy AIja2026-09-24T08:06:51-07:00米国のプライマリ・ケアにおける非嚢胞性線維症気管支拡張症の負担の継続的増大：2015～2025年の有病率の推移と人口統計学的特性の分析 https://news.medxy.ai/vi/bronchiectasis-us-increase/Medxy AIvi2026-09-24T08:06:33-07:00Giãn phế quản không do xơ nang tại chăm sóc ban đầu ở Hoa Kỳ gia tăng rõ rệt: Xu hướng hiện mắc trong một thập kỷ và đặc điểm nhân khẩu học (2015–2025) https://news.medxy.ai/non-cystic-bronchiectasis/Medxy AIen2026-09-24T08:06:16-07:00Rising Burden of Non-Cystic Fibrosis Bronchiectasis in U.S. Primary Care: A Decade of Prevalence Trends and Demographic Insights (2015–2025) https://news.medxy.ai/zh/airway-assessment-pediatric-arrest/Medxy AIzh2026-09-24T08:00:34-07:00通过波形二氧化碳描记法评估气道通畅性，优化儿科心搏骤停结局 https://news.medxy.ai/ja/77181-2/Medxy AIja2026-09-24T08:00:17-07:00波形二酸化炭素分圧モニタリングによる気道開存性の評価と小児心停止の転帰の最適化 https://news.medxy.ai/vi/pediatric-cardiac-arrest-3/Medxy AIvi2026-09-24T07:59:56-07:00Tối ưu hóa kết cục ngừng tim ở trẻ em thông qua đánh giá tình trạng thông thoáng đường thở bằng capnography https://news.medxy.ai/optimizing-pediatric-cardiac-arrest-outcomes-through-airway-patency-assessment-via-capnography/Medxy AIen2026-09-24T07:59:39-07:00Optimizing Pediatric Cardiac Arrest Outcomes through Airway Patency Assessment via Capnography https://news.medxy.ai/zh/retinal-vessel-glaucoma/Medxy AIzh2026-09-24T07:59:03-07:00自动眼底摄影揭示：视网膜血管特征可预测原发性开角型青光眼的视野进展 https://news.medxy.ai/ja/77176-2/Medxy AIja2026-09-24T07:58:45-07:00自動眼底撮影による解析：網膜血管の特性は原発開放隅角緑内障における視野進行を予測し得る https://news.medxy.ai/vi/retinal-vessel-quantification/Medxy AIvi2026-09-24T07:58:26-07:00Định lượng mạch máu võng mạc có dự báo tiến triển thị trường ở tăng nhãn áp góc mở nguyên phát? Phân tích từ ảnh đáy mắt tự động https://news.medxy.ai/retinal-vasculometry-predicts-visual-field-progression-in-primary-open-angle-glaucoma-insights-from-automated-fundus-photography-analysis/Medxy AIen2026-09-24T07:58:09-07:00Retinal Vasculometry Predicts Visual Field Progression in Primary Open Angle Glaucoma: Insights from Automated Fundus Photography Analysis https://news.medxy.ai/zh/stevens-johnson-vision-loss/Medxy AIzh2026-09-24T07:57:32-07:00慢性 Stevens-Johnson 综合征视力丧失的预测因素：来自全国多中心队列研究的启示 https://news.medxy.ai/ja/stevens-johnson-vision/Medxy AIja2026-09-24T07:57:14-07:00慢性Stevens-Johnson症候群における視力低下の予測因子：全国多施設コホート研究からの知見 https://news.medxy.ai/vi/vision-loss-prediction-stevens-johnson/Medxy AIvi2026-09-24T07:56:57-07:00Yếu tố dự báo mất thị lực trong Stevens-Johnson syndrome mạn tính: Góc nhìn từ một nghiên cứu đoàn hệ đa trung tâm trên phạm vi toàn quốc https://news.medxy.ai/predictors-of-vision-loss-in-chronic-stevens-johnson-syndrome-insights-from-a-nationwide-multicenter-cohort-study/Medxy AIen2026-09-24T07:56:39-07:00Predictors of Vision Loss in Chronic Stevens-Johnson Syndrome: Insights from a Nationwide Multicenter Cohort Study https://news.medxy.ai/zh/laryngoscopy-smart-assessment/Medxy AIzh2026-09-24T07:56:02-07:00喉镜检查迈向实时智能评估：基于声带运动学的喉功能行为分类 https://news.medxy.ai/ja/larynx-function-analysis/Medxy AIja2026-09-24T07:55:48-07:00声帯運動学で切り拓く喉頭検査の新展開：機能的喉頭行動をリアルタイム分類 https://news.medxy.ai/vi/real-time-vocal-fold-analysis/Medxy AIvi2026-09-24T07:55:30-07:00Nâng tầm thăm khám thanh quản: Phân loại hành vi chức năng theo thời gian thực dựa trên động học dây thanh âm https://news.medxy.ai/advancing-laryngeal-examination-real-time-functional-behavior-classification-via-vocal-fold-kinematics/Medxy AIen2026-09-24T07:55:14-07:00Advancing Laryngeal Examination: Real-Time Functional Behavior Classification via Vocal Fold Kinematics https://news.medxy.ai/zh/dysphagia-surgery-outcomes/Medxy AIzh2026-09-23T08:54:40-07:00衰弱是否会影响环咽肌功能障碍手术结局？——优化患者筛选与预期管理 https://news.medxy.ai/ja/pharyngeal-muscle-frailty/Medxy AIja2026-09-23T08:54:21-07:00輪状咽頭筋機能障害における手術転帰予測因子としてのフレイル：患者選択と期待値設定の最適化 https://news.medxy.ai/vi/surgery-outcomes-prediction/Medxy AIvi2026-09-23T08:54:01-07:00Suy yếu có dự báo kết quả phẫu thuật trong rối loạn chức năng cơ nhẫn hầu không? Tối ưu lựa chọn bệnh nhân và kỳ vọng điều trị https://news.medxy.ai/frailty-as-a-predictor-of-surgical-outcomes-in-cricopharyngeus-muscle-dysfunction-enhancing-patient-selection-and-expectations/Medxy AIen2026-09-23T08:53:43-07:00Frailty as a Predictor of Surgical Outcomes in Cricopharyngeus Muscle Dysfunction: Enhancing Patient Selection and Expectations https://news.medxy.ai/zh/chronic-rhinosinusitis-pathology/Medxy AIzh2026-09-23T08:53:02-07:00鼻内物质使用相关慢性鼻-鼻窦炎的组织病理学新认识：对临床管理的启示 https://news.medxy.ai/ja/77156-2/Medxy AIja2026-09-23T08:52:44-07:00鼻腔内物質に関連する慢性鼻副鼻腔炎の組織病理学的知見：臨床管理への示唆 https://news.medxy.ai/vi/chronic-rhinosinusitis-findings/Medxy AIvi2026-09-23T08:52:24-07:00Những phát hiện mô bệnh học trong viêm mũi xoang mạn tính liên quan đến sử dụng chất qua đường mũi: hàm ý cho quản lý lâm sàng https://news.medxy.ai/histopathologic-insights-in-chronic-rhinosinusitis-linked-to-intranasal-substance-use-implications-for-clinical-management/Medxy AIen2026-09-23T08:52:05-07:00Histopathologic Insights in Chronic Rhinosinusitis Linked to Intranasal Substance Use: Implications for Clinical Management https://news.medxy.ai/zh/environmental-impact-surgery/Medxy AIzh2026-09-23T08:51:28-07:00环境负担如何影响手术结局：揭开隐匿的健康差异 https://news.medxy.ai/ja/environmental-impact-surgery-2/Medxy AIja2026-09-23T08:51:14-07:00環境負荷は外科成績にどう影響するのか――見えにくい格差を読み解く https://news.medxy.ai/vi/environmental-burden-surgery-impact/Medxy AIvi2026-09-23T08:50:55-07:00Gánh nặng môi trường và tác động lên kết cục phẫu thuật: hé lộ những chênh lệch ẩn giấu https://news.medxy.ai/environmental-burden-and-its-influence-on-surgical-outcomes-unveiling-the-hidden-disparities/Medxy AIen2026-09-23T08:50:36-07:00Environmental Burden and Its Influence on Surgical Outcomes: Unveiling the Hidden Disparities https://news.medxy.ai/zh/automated-gastrectomy-quality/Medxy AIzh2026-09-23T08:49:57-07:00远端胃切除术质量评估再升级：基于计算机视觉的质量关键视野自动化判读 https://news.medxy.ai/ja/gastrectomy-quality-evaluation/Medxy AIja2026-09-23T08:49:39-07:00遠位胃切除術の手術品質評価を前進させる：Computer Vision による Critical View of Quality の自動解析 https://news.medxy.ai/vi/surgical-quality-assessment-2/Medxy AIvi2026-09-23T08:49:21-07:00Nâng tầm đánh giá chất lượng phẫu thuật trong cắt dạ dày xa: Đánh giá tự động Critical View of Quality bằng computer vision https://news.medxy.ai/advancing-surgical-quality-assessment-in-distal-gastrectomy-automated-evaluation-of-the-critical-view-of-quality-using-computer-vision/Medxy AIen2026-09-23T08:49:02-07:00Advancing Surgical Quality Assessment in Distal Gastrectomy: Automated Evaluation of the Critical View of Quality Using Computer Vision https://news.medxy.ai/zh/neurotensin-receptor1/Medxy AIzh2026-09-23T08:48:26-07:00神经降压素受体1：驱动结直肠癌免疫排斥与不良预后的关键因素 https://news.medxy.ai/ja/neurotensin-receptor1-colon-cancer/Medxy AIja2026-09-23T08:48:09-07:00ニューロテンシン受容体1が切り拓く大腸がんの免疫排除機構と予後不良の鍵 https://news.medxy.ai/vi/neurotensin-receptor-1/Medxy AIvi2026-09-23T08:47:51-07:00Thụ thể Neurotensin 1: Động lực then chốt của hiện tượng loại trừ miễn dịch và tiên lượng xấu trong ung thư đại trực tràng https://news.medxy.ai/neurotensin-receptor-1-a-key-driver-of-immune-exclusion-and-poor-prognosis-in-colorectal-cancer/Medxy AIen2026-09-23T08:47:32-07:00Neurotensin Receptor 1: A Key Driver of Immune Exclusion and Poor Prognosis in Colorectal Cancer https://news.medxy.ai/zh/early-treatment-severe-preeclampsia/Medxy AIzh2026-09-23T08:46:50-07:00早发型重度子痫前期中降压治疗升级：期待治疗期间母体风险的动态标志 https://news.medxy.ai/ja/early-severe-preeclampsia/Medxy AIja2026-09-23T08:46:33-07:00早発性重症子癇前症における降圧治療増強：待機的管理中の母体リスクを示す動的マーカー https://news.medxy.ai/vi/early-pre-eclampsia-treatment/Medxy AIvi2026-09-23T08:46:13-07:00Tăng cường điều trị hạ huyết áp trong tiền sản giật khởi phát sớm có đặc điểm nặng: chỉ dấu động về nguy cơ mẹ trong xử trí theo dõi chờ đợi https://news.medxy.ai/escalating-antihypertensive-therapy-in-early-onset-severe-preeclampsia-dynamic-marker-of-maternal-risk-during-expectant-management/Medxy AIen2026-09-23T08:45:53-07:00Escalating Antihypertensive Therapy in Early-Onset Severe Preeclampsia: Dynamic Marker of Maternal Risk During Expectant Management https://news.medxy.ai/laparoscopic-modified-davydovs-technique-for-vaginoplasty-operative-steps-and-technical-pearls/Medxy AIen2026-09-23T08:45:15-07:00Laparoscopic Modified Davydov’s Technique for Vaginoplasty: Operative Steps and Technical Pearls https://news.medxy.ai/zh/ontario-hysterectomy-trends/Medxy AIzh2026-09-23T08:44:39-07:00安大略省门诊子宫切除术的上升趋势及临床结局：基于人群的分析 https://news.medxy.ai/ja/77114-2/Medxy AIja2026-09-23T08:44:23-07:00オンタリオ州における外来子宮摘出術の増加傾向と臨床的転帰：集団ベースの解析 https://news.medxy.ai/vi/outpatient-hysterectomy-ontario/Medxy AIvi2026-09-23T08:44:05-07:00Cắt tử cung ngoại trú tại Ontario tăng nhanh cùng kết cục lâm sàng khả quan: phân tích dựa trên quần thể https://news.medxy.ai/rising-trends-and-clinical-outcomes-of-outpatient-hysterectomy-in-ontario-a-population-based-analysis/Medxy AIen2026-09-23T08:43:47-07:00Rising Trends and Clinical Outcomes of Outpatient Hysterectomy in Ontario: A Population-Based Analysis https://news.medxy.ai/zh/microbiome-necrotizing-enterocolitis/Medxy AIzh2026-09-23T08:43:10-07:00坏死性小肠结肠炎中的微生物差异机制与预测特征：肠道噬菌体与细菌耐药组的作用 https://news.medxy.ai/ja/necrotizing-enterocolitis-mechanisms/Medxy AIja2026-09-23T08:42:49-07:00壊死性腸炎における微生物機序の分岐と予測シグネチャー：腸内ファージと細菌レジストームの役割 https://news.medxy.ai/vi/77103-2/Medxy AIvi2026-09-23T08:42:25-07:00Sự phân hóa cơ chế vi sinh và các dấu ấn dự báo trong bệnh viêm ruột hoại tử: Vai trò của thể thực khuẩn đường ruột và hệ gen kháng thuốc của vi khuẩn (resistome) https://news.medxy.ai/divergent-microbial-mechanisms-and-predictive-signatures-in-necrotising-enterocolitis-the-role-of-gut-phages-and-bacterial-resistomes/Medxy AIen2026-09-23T08:42:03-07:00Divergent Microbial Mechanisms and Predictive Signatures in Necrotising Enterocolitis: The Role of Gut Phages and Bacterial Resistomes https://news.medxy.ai/zh/chronic-hepatitis-b/Medxy AIzh2026-09-23T08:41:16-07:00重新审视慢性乙型肝炎的免疫耐受期：RADICAL联盟揭示高转归率及其临床启示 https://news.medxy.ai/ja/chronic-hepatitis-b-2/Medxy AIja2026-09-23T08:40:55-07:00慢性B型肝炎の免疫寛容期を再考する：免疫活性病態への高い移行率とRADICAL consortiumが示す臨床的示唆 https://news.medxy.ai/vi/immune-tolerance-hepatitis-b/Medxy AIvi2026-09-23T08:40:33-07:00Xem xét lại pha dung nạp miễn dịch trong viêm gan B mạn tính: Tỷ lệ chuyển cao sang bệnh hoạt động miễn dịch và ý nghĩa lâm sàng từ liên minh RADICAL https://news.medxy.ai/reevaluating-immune-tolerant-phase-in-chronic-hepatitis-b-high-transition-rates-to-immune-active-disease-and-clinical-implications-from-the-radical-consortium/Medxy AIen2026-09-23T08:40:14-07:00Reevaluating Immune Tolerant Phase in Chronic Hepatitis B: High Transition Rates to Immune Active Disease and Clinical Implications from the RADICAL Consortium https://news.medxy.ai/zh/epilepsy-cause-evaluation/Medxy AIzh2026-09-23T08:39:34-07:00优化癫痫持续状态后的病因学评估：来自ICTAL登记研究的诊断获益与治疗启示 https://news.medxy.ai/ja/optimize-epilepsy-diagnosis/Medxy AIja2026-09-23T08:39:17-07:00けいれん重積状態後の病因検索を最適化する：ICTALレジストリが示す診断的有用性と治療への影響 https://news.medxy.ai/vi/epilepsy-investigation-optimization/Medxy AIvi2026-09-23T08:38:55-07:00Tối ưu hóa thăm dò căn nguyên sau trạng thái động kinh: Giá trị chẩn đoán và ý nghĩa điều trị từ sổ đăng ký ICTAL https://news.medxy.ai/optimizing-etiologic-investigations-after-status-epilepticus-diagnostic-yield-and-therapeutic-implications-from-the-ictal-registry/Medxy AIen2026-09-23T08:38:35-07:00Optimizing Etiologic Investigations After Status Epilepticus: Diagnostic Yield and Therapeutic Implications from the ICTAL Registry https://news.medxy.ai/ja/77090-2/Medxy AIja2026-09-23T08:37:32-07:00アルツハイマー病におけるタウPET病期分類のための統合的目視読影フレームワーク https://news.medxy.ai/vi/harmonious-image-reading/Medxy AIvi2026-09-23T08:37:12-07:00Một khung đọc hình ảnh hài hòa để phân giai đoạn Tau PET trong bệnh Alzheimer https://news.medxy.ai/a-harmonized-visual-reading-framework-for-tau-pet-staging-in-alzheimer-disease/Medxy AIen2026-09-23T08:36:54-07:00A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease https://news.medxy.ai/ja/quantitative-insights/Medxy AIja2026-09-23T08:34:57-07:00縦断的システムモデリングで読み解くチルゼパチドとセマグルチドの定量的知見 https://news.medxy.ai/vi/tirzepatide-semaglutide-power/Medxy AIvi2026-09-23T08:34:40-07:00Tiết lộ sức mạnh của Tirzepatide và Semaglutide qua mô hình hệ thống dọc https://news.medxy.ai/quantitative-insights-into-tirzepatide-and-semaglutide-using-longitudinal-systems-modeling/Medxy AIen2026-09-23T08:34:22-07:00Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling https://news.medxy.ai/zh/77077-2/Medxy AIzh2026-09-23T08:33:44-07:00PPARγ激动剂与GLP-1受体激动剂在中枢神经系统胰岛素抵抗中的作用 https://news.medxy.ai/ja/brain-metabolism-biomarkers/Medxy AIja2026-09-23T08:33:23-07:00神経由来細胞外小胞バイオマーカーから読む脳代謝：CNSインスリン抵抗性におけるPPARγ作動薬とGLP1受容体作動薬の役割 https://news.medxy.ai/vi/neuron-exosome-biomarkers/Medxy AIvi2026-09-23T08:32:59-07:00Dấu ấn sinh học từ túi ngoại bào nguồn gốc neuron: PPARγ và chất chủ vận thụ thể GLP1 điều biến chuyển hóa não trong kháng insulin của CNS https://news.medxy.ai/brain-metabolism-insights/Medxy AIen2026-09-23T08:32:37-07:00Insights from Neuron-Derived Extracellular Vesicle Biomarkers: PPARγ and GLP1 Receptor Agonists Modulate Brain Metabolism in CNS Insulin Resistance https://news.medxy.ai/zh/pediatric-thyroid-cancer/Medxy AIzh2026-09-23T08:31:45-07:00儿童分化型甲状腺癌：来自儿童与青少年甲状腺联盟的侵袭性疾病预测因素及治疗结局洞见 https://news.medxy.ai/ja/pediatric-thyroid-cancer-2/Medxy AIja2026-09-23T08:31:28-07:00小児分化型甲状腺癌：CATCが示す浸潤性病変の予測因子と治療成績 https://news.medxy.ai/vi/differentiated-thyroid-cancer-children/Medxy AIvi2026-09-23T08:31:06-07:00Ung thư tuyến giáp biệt hóa ở trẻ em: phát hiện từ Child and Adolescent Thyroid Consortium về các yếu tố dự báo bệnh xâm lấn và kết quả điều trị https://news.medxy.ai/pediatric-differentiated-thyroid-carcinoma-insights-from-the-child-and-adolescent-thyroid-consortium-on-invasive-disease-predictors-and-treatment-outcomes/Medxy AIen2026-09-23T08:30:48-07:00Pediatric Differentiated Thyroid Carcinoma: Insights from the Child and Adolescent Thyroid Consortium on Invasive Disease Predictors and Treatment Outcomes